Editorial Policy | Potent Peptide Research Standards
PotentPeptide

Editorial policy

Research process

Editorial work starts with the mechanism, then checks human evidence, clinical-trial records, regulatory status, safety signals, and product context. Pages separate studied endpoints from informal claims.

Source hierarchy

Primary studies, clinical trials, systematic reviews, regulatory bodies, and official sport-governance sources carry the most weight. Vendor claims and user anecdotes are treated as lower-quality evidence.

Conflict of interest policy

Affiliate relationships may exist with vendors linked from the site. Commission potential should not change page conclusions, safety notes, or source selection.

Corrections

Correction requests should include the page URL, the claim in question, and the source that supports the correction. A verified contact channel is still needed for the final request process.

AI assistance disclosure

AI tools may assist with drafting, formatting, and consistency checks. Human review is required before publication, especially for medical, legal, regulatory, and citation-sensitive claims.